Global Piperazine Ferulate Market Size, Share and Trends Analysis Report, By Application (Nephritis, Early Uremia, Ischemic Heart Disease, and Others), Forecast Period (2022-2028)

The global piperazine ferulate market is anticipated to grow at a CAGR of 3.8% during the forecast period (2022-2028). Piperazine ferulate is a ferulic acid derivative that has been used in China to treat a variety of glomerular diseases, such as nephritis and nephritic syndrome. A clinical trial involving immunoglobulin in children. Piperazine ferulate tablets in combination with eucalyptol-limonene-pinene enteric soft capsules were found to be safe and effective in the treatment of nephropathy. Piperazine ferulate has also been shown to suppress TGF-1-induced renal interstitial fibroblast activation and extracellular matrix formation in TGF-1-induced mesangial cells.

According to the National Library of Medicine, chronic kidney disease has been identified as a major public health issue around the globe. Patients with end-stage kidney disease who require renal replacement treatment are projected to number between 4.902 and 7.083 million globally. With such a large consumer base who is going to require the piperazine ferulate medicine in the future is going to show a positive impact in the piperazine ferulate industry.

According to the National Library of Medicine, ischemic heart disease affects around 126 million individuals (1,655 per 100,000), which is approximately 1.72% of the global population. Nine million deaths were caused by IHD globally Men were more usually affected than women, and the disease first appeared in the fourth decade and became more common as people became older. IHD is becoming more common over the globe. By 2030, the current prevalence rate of 1,655 per 100,000 people is predicted to rise to 1,845 per 100,000 people. With such rising cases of chronic diseases, the need for piperazine ferulate will grow in the forecast period.

Some major players in the market include Chengdu Hengda Pharmaceutical Co., Ltd., GlaxoSmithKline plc, HAINAN LINHENG PHARMACEUTICAL CO., LTD., Kangpu Biopharmaceuticals, Ltd., Shandong Xier Kangtai Pharmaceutical Co., LTD., among others. The market players are contributing significantly to the growth of the market by the adoption of various strategies including mergers and acquisitions, geographical expansion, partnerships, collaborations, and new product launches, to stay competitive in the market.

Company and its Products

Torque Pharmaceuticals Pvt Ltd offers Actipar Syrup, It is a medication that aids in the treatment of a variety of parasitic worm illnesses. It works by eradicating and preventing the parasites that are causing the infection from spreading. This drug usually works immediately to make a person feel better.

GlaxoSmithKline plc offers 750mg Antepar Syrup, which works as an anti-helminthic. It’s a drug that’s used to treat worm infestations. It works by destroying the worms that cause the infection. After that, the worms that have been killed are passed into the stool.

Market Coverage

• The market number available for – 2021-2028
• Base year- 2021
• Forecast period- 2022-2028
• Segment Covered-
  • By Application
• Regions Covered-
  • North America
  • Europe
  • Asia-Pacific
  • Rest of the World
• Competitive Landscape- Chengdu Hengda Pharmaceutical Co., Ltd., GlaxoSmithKline plc, HAINAN LINHENG PHARMACEUTICAL CO., LTD., Kangpu Biopharmaceuticals, Ltd., Shandong Xier Kangtai Pharmaceutical Co., LTD., among others.

Key questions addressed by the report

• What is the market growth rate?
• Which segment and region dominate the market in the base year?
• Which segment and region will project the fastest growth in the market?
• How has COVID-19 impacted the market?
  • Deviation from the pre-COVID-19 forecast
  • Most affected region and segment
• Who is the leader in the market?
• How players are addressing challenges to sustain growth?
• Where is the investment opportunity?

Global Piperazine Ferulate Market Report by Segment

By Application

• Nephritis
• Early Uremia
• Ischemic Heart Disease
• Others (Cerebral Infarction and vasculitis)

Global Piperazine Ferulate Market Report by Region

North America

• United States
• Canada

Europe

• UK
• Germany
• Italy
• Spain
• France
• Rest of Europe

Asia-Pacific

• China
• India
• Japan
• South Korea
• Rest of Asia-Pacific

Rest of the World

• Latin America
• Middle East & Africa